Aflac Incorporated (NYSE:AFL – Get Free Report) Director Masatoshi Koide sold 13,201 shares of Aflac stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $118.01, for a total value of $1,557,850.01. Following the transaction, the director directly owned 76,422 shares of the company’s stock, valued at $9,018,560.22. The trade was a 14.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Aflac Price Performance
Shares of AFL stock traded down $0.28 during trading hours on Friday, reaching $116.32. The stock had a trading volume of 6,727,380 shares, compared to its average volume of 2,345,028. The stock’s fifty day simple moving average is $120.74 and its 200 day simple moving average is $116.46. The firm has a market capitalization of $58.31 billion, a PE ratio of 12.47, a PEG ratio of 1.88 and a beta of 0.59. Aflac Incorporated has a 12 month low of $105.43 and a 12 month high of $130.22. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 0.29.
Aflac (NYSE:AFL – Get Free Report) last posted its earnings results on Thursday, August 6th. The financial services provider reported $1.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.76 by ($0.01). The firm had revenue of $4.22 billion during the quarter, compared to analysts’ expectations of $4.11 billion. Aflac had a return on equity of 13.27% and a net margin of 26.91%.The business’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.78 earnings per share. On average, equities research analysts predict that Aflac Incorporated will post 7.04 EPS for the current year.
Aflac Dividend Announcement
Analyst Upgrades and Downgrades
Several brokerages have issued reports on AFL. TD Cowen reiterated a “hold” rating and set a $110.00 target price (up from $101.00) on shares of Aflac in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. dropped their price objective on shares of Aflac from $117.00 to $116.00 and set a “neutral” rating for the company in a report on Tuesday, August 11th. Wolfe Research began coverage on Aflac in a research report on Wednesday, August 19th. They set an “underperform” rating and a $103.00 price target on the stock. Wall Street Zen cut Aflac from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Finally, Jefferies Financial Group reissued a “hold” rating and set a $108.00 price objective (up from $100.00) on shares of Aflac in a report on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, Aflac currently has an average rating of “Hold” and a consensus price target of $116.62.
Check Out Our Latest Analysis on Aflac
Institutional Trading of Aflac
Several hedge funds and other institutional investors have recently bought and sold shares of AFL. Employees Retirement System of Texas bought a new position in shares of Aflac in the 4th quarter worth approximately $3,743,000. Meiji Yasuda Asset Management Co Ltd. bought a new stake in shares of Aflac during the second quarter valued at approximately $6,630,000. Atlas Wealth LLC bought a new stake in shares of Aflac during the first quarter valued at approximately $1,802,000. Fifth Third Bancorp grew its stake in Aflac by 135.5% in the first quarter. Fifth Third Bancorp now owns 142,180 shares of the financial services provider’s stock worth $15,599,000 after purchasing an additional 81,803 shares during the period. Finally, Callan Family Office LLC purchased a new stake in Aflac in the second quarter worth $2,546,000. Institutional investors own 67.44% of the company’s stock.
About Aflac
Aflac Incorporated is an insurance company that provides supplemental health and life insurance products. Its coverage is designed to help policyholders manage expenses that may not be fully covered by major medical insurance, including costs associated with accidents, illness, hospitalization, disability and critical illness.
Through its U.S. operations, Aflac markets policies to individuals, businesses and employees through workplace benefit programs, independent agents and brokers. The company is also a major provider of supplemental insurance in Japan, where it offers products focused primarily on cancer, medical and income-support coverage.
Founded in 1955 in Columbus, Georgia, as American Family Life Assurance Company, the business adopted the name Aflac in 1990.
Recommended Stories
- Five stocks we like better than Aflac
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
